The paper titled, "Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects," was published in the Proceedings of the National Academy of Sciences of the United States of America journal.
University of Florida College of Pharmacy graduate students Amy Alleyne and Corey Perkins earned second place awards in the UF Graduate Student Diversity Research Day poster contest, April 6.
GLP-1 plays an important role in regulating appetite by creating the sensation of feeling full after a meal. UF's findings could have far-reaching implications for developing new medicines designed to treat obesity.
The grant will support the development of CP-analogs as novel treatments for opioid use disorder.
An anticancer drug developed by researchers from the University of Florida College of Pharmacy has become the first drug of its kind allowed to proceed to clinical trial by the U.S. Food and Drug Administration.
Ariana Brice-Tutt's final defense was presented March 10.
UF pharmacy researchers have found a potential new way of targeting a population of immune-suppressive T cells that could possibly benefit a large population of cancer patients, including those who will not respond to other immunotherapies.
A tissue-chip experiment led by Siobhan Malany, Ph.D., an associate professor of pharmacodynamics in the University of Florida College of Pharmacy, returned to Earth Jan. 13.
The grant will help to develop novel senolytic agents and identify molecular targets that are important for survival of senescent cells.
The study led by Siobhan Malany, Ph.D., will help scientists understand microgravity effects on human muscle cells and could aid the development of new therapies for age-related muscle loss on Earth.
